Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

• Main Authors: Patricia Vella Bonanno (Author), Michael Ermisch (Author), Brian Godman (Author), Antony P. Martin (Author), Jesper Van Den Bergh (Author), Liudmila Bezmelnitsyna (Author), Anna Bucsics (Author), Francis Arickx (Author), Alexander Bybau (Author), Tomasz Bochenek (Author), Marc van de Casteele (Author), Eduardo Diogene (Author), Irene Eriksson (Author), Jurij Fürst (Author), Mohamed Gad (Author), Ieva Greičiūtė-Kuprijanov (Author), Martin van der Graaff (Author), Jolanta Gulbinovic (Author), Jan Jones (Author), Roberta Joppi (Author), Marija Kalaba (Author), Ott Laius (Author), Irene Langner (Author), Ileana Mardare (Author), Vanda Markovic-Pekovic (Author), Einar Magnusson (Author), Oyvind Melien (Author), Dmitry O. Meshkov (Author), Guenka I. Petrova (Author), Gisbert Selke (Author), Catherine Sermet (Author), Steven Simoens (Author), Ad Schuurman (Author), Ricardo Ramos (Author), Jorge Rodrigues (Author), Corinne Zara (Author), Eva Zebedin-Brandl (Author), Alan Haycox (Author)
• Format: Book
• Published: Frontiers Media S.A., 2017-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Medicines receiving a conditional marketing authorization through Medicines Adaptive Pathways to Patients (MAPPs) will be a challenge for payers. The "introduction" of MAPPs is already seen by the European Medicines Agency (EMA) as a fait accompli, with payers not consulted or involved. Ho...